New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Immunotherapy for blood cancer: Remote destruction of tumor cells demonstrated

Immunotherapy for blood cancer: Remote destruction of tumor cells demonstrated

byPasteur InstituteGating strategies for flow cytometry identification of pro-B-cell tumors. (a) Gating strategy for identifying pro-B-cell tumors expressing the FRET-based caspase 3 reporter (n
Oncology January 15,2024
Immunotherapy for blood cancer: Remote destruction of tumor cells demonstrated

Immunotherapy for blood cancer: Remote destruction of tumor cells demonstrated

byPasteur InstituteGating strategies for flow cytometry identification of pro-B-cell tumors. (a) Gating strategy for identifying pro-B-cell tumors expressing the FRET-based caspase 3 reporter (n
Oncology January 15,2024
Selective nodal radiation may be a more effective approach in cancer treatment

Selective nodal radiation may be a more effective approach in cancer treatment

byCU Anschutz Medical CampusENI ablates the immune response to combined radiation and immunotherapy. A Schematic of the experimental design for gross tumor irradiation with or without elective n
Oncology January 15,2024
Selective nodal radiation may be a more effective approach in cancer treatment

Selective nodal radiation may be a more effective approach in cancer treatment

byCU Anschutz Medical CampusENI ablates the immune response to combined radiation and immunotherapy. A Schematic of the experimental design for gross tumor irradiation with or without elective n
Oncology January 15,2024
Hunting brain cancer cells: Neuronal and tumorigenic boundaries of glioblastoma plasticity

Hunting brain cancer cells: Neuronal and tumorigenic boundaries of glioblastoma plasticity

byFlinders UniversityGlioblastoma tumor cells express aberrant neuronal signatures and differentiate along a neurodevelopmental trajectory. (A) Healthy neuronal cells transform to a malignant ph
Oncology January 15,2024
Hunting brain cancer cells: Neuronal and tumorigenic boundaries of glioblastoma plasticity

Hunting brain cancer cells: Neuronal and tumorigenic boundaries of glioblastoma plasticity

byFlinders UniversityGlioblastoma tumor cells express aberrant neuronal signatures and differentiate along a neurodevelopmental trajectory. (A) Healthy neuronal cells transform to a malignant ph
Oncology January 15,2024
Blood cancer research points to new treatment for bone marrow cancer

Blood cancer research points to new treatment for bone marrow cancer

byUniversity of VirginiaDeletion of IL-1R1 preferentially inhibits Jak2V617F mutant hematopoietic stem/progenitor cells.aA scheme on competitive BM transplantation approach to assess
Oncology January 15,2024
Blood cancer research points to new treatment for bone marrow cancer

Blood cancer research points to new treatment for bone marrow cancer

byUniversity of VirginiaDeletion of IL-1R1 preferentially inhibits Jak2V617F mutant hematopoietic stem/progenitor cells.aA scheme on competitive BM transplantation approach to assess
Oncology January 15,2024
New model identifies women at high risk for endometrial cancer

New model identifies women at high risk for endometrial cancer

byBrigham and Women's HospitalInclusion and exclusion of study participants from NHS II. Credit:JNCI: Journal of the National Cancer Institute(2023). DOI: 10.1093/jnci/djad014End
Oncology January 15,2024
New model identifies women at high risk for endometrial cancer

New model identifies women at high risk for endometrial cancer

byBrigham and Women's HospitalInclusion and exclusion of study participants from NHS II. Credit:JNCI: Journal of the National Cancer Institute(2023). DOI: 10.1093/jnci/djad014End
Oncology January 15,2024
Criteria for selecting who can enroll in multiple myeloma clinical trials may exclude patients from minority groups

Criteria for selecting who can enroll in multiple myeloma clinical trials may exclude patients from minority groups

byAmerican Society of HematologyCredit: Unsplash/CC0 Public DomainNumerous studies have shown that people from racial and ethnic minority groups are underrepresented in clinical trials of new me
Oncology January 15,2024
Criteria for selecting who can enroll in multiple myeloma clinical trials may exclude patients from minority groups

Criteria for selecting who can enroll in multiple myeloma clinical trials may exclude patients from minority groups

byAmerican Society of HematologyCredit: Unsplash/CC0 Public DomainNumerous studies have shown that people from racial and ethnic minority groups are underrepresented in clinical trials of new me
Oncology January 15,2024
Exercise protects breast cancer patients' hearts against chemotherapy drugs, new study finds

Exercise protects breast cancer patients' hearts against chemotherapy drugs, new study finds

by Baker Heart & Diabetes InstituteCredit: Unsplash/CC0 Public DomainCardiovascular disease is the leading cause of mortality in breast cancer survivors. A new study out of the Baker Heart and Dia
Oncology January 15,2024
Exercise protects breast cancer patients' hearts against chemotherapy drugs, new study finds

Exercise protects breast cancer patients' hearts against chemotherapy drugs, new study finds

by Baker Heart & Diabetes InstituteCredit: Unsplash/CC0 Public DomainCardiovascular disease is the leading cause of mortality in breast cancer survivors. A new study out of the Baker Heart and Dia
Oncology January 15,2024
A select group: Study may bring improved therapy to preselected lung cancer patients

A select group: Study may bring improved therapy to preselected lung cancer patients

byWeizmann Institute of ScienceGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101142Nonsmokers who develop lung cancer can be treated effectively wi
Oncology January 15,2024
A select group: Study may bring improved therapy to preselected lung cancer patients

A select group: Study may bring improved therapy to preselected lung cancer patients

byWeizmann Institute of ScienceGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101142Nonsmokers who develop lung cancer can be treated effectively wi
Oncology January 15,2024
Deciphering reproductive aging in women using a NOD/SCID mouse model

Deciphering reproductive aging in women using a NOD/SCID mouse model

by Impact Journals LLCMitochondrial function in the ovaries of a NOD/SCID mouse model for physiological human aging. Credit:Aging(2023). DOI: 10.18632/aging.205086A newresearch paper
OB & GYN January 15,2024
Deciphering reproductive aging in women using a NOD/SCID mouse model

Deciphering reproductive aging in women using a NOD/SCID mouse model

by Impact Journals LLCMitochondrial function in the ovaries of a NOD/SCID mouse model for physiological human aging. Credit:Aging(2023). DOI: 10.18632/aging.205086A newresearch paper
OB & GYN January 15,2024
Shift work and long hours significantly increase risk of preterm birth: Study

Shift work and long hours significantly increase risk of preterm birth: Study

byMonash UniversityCredit: Pixabay/CC0 Public DomainShift work and working long hours significantly increase the chances of preterm birth, a Monash University-led study has found.The researchers
OB & GYN January 15,2024
Shift work and long hours significantly increase risk of preterm birth: Study

Shift work and long hours significantly increase risk of preterm birth: Study

byMonash UniversityCredit: Pixabay/CC0 Public DomainShift work and working long hours significantly increase the chances of preterm birth, a Monash University-led study has found.The researchers
OB & GYN January 15,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com